Trump Administration has withdrawn the proposed ban on menthol cigarettes and flavored cigars in the U.S., which has been looming over the tobacco industry since the FDA’s initial proposal in April of 2022, Citi tells investors in a research note. The firm the confirmed withdrawal is a “significant positive” for each of British American Tobacco (BTI), Altria Group (MO) and Imperial (IMBBY). Around 33% of the U.S. cigarette market in 2023 was menthol, and Citi estimates that U.S. menthol cigarettes account for 25% of British American’s and Altria’s operating profit globally and 10% of Imperial’s, the analyst notes.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MO:
- Trump administration withdraws FDA ban on menthol cigarettes
- FDA authorizes marketing of 20 Zyn nicotine pouch products
- Netflix upgraded, AMD downgraded: Wall Street’s top analyst calls
- Altria Group initiated with an Equal Weight at Morgan Stanley
- FDA proposes plan to make cigarettes ‘nonaddictive’ by limiting tobacco
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue